Connect your AI

Henry Schein HSIC Restructuring Reserve Settled Without Cash2

Restructuring Reserve Settled Without Cash2 at other companies

West Pharmaceutical ServicesWST

$900K+12.5%

Other financials

Income statement

Revenue$3.4B+6.3%

Gross profit$1.1B+7.0%

Operating income$182.0M+4.0%

Net income$107.0M-2.7%

EPS (diluted)$0.92+4.5%

Balance sheet

Cash & equivalents$138.0M+8.7%

Total debt$3.7B+17.2%

Total equity$3.3B-1.3%

Total assets$11.3B+7.9%

Cash flow

Operating cash flow-$97.0M-362%

CapEx$25.0M-19.4%

Free cash flow-$122.0M-2,133%

Valuation

Market cap$9.1B-0.6%

Enterprise value$12.69B+4.2%

P/E23.1×+0.5×

P/S0.7×0.0×

Profitability

Gross margin31.2%-0.4pp

Operating margin4.9%-0.2pp

Net margin3%-0.3pp

FCF margin3.3%-1.0pp

Returns & leverage

Return on equity12%+0.2pp

Debt / equity1.1×+0.2×

Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept us-gaap:RestructuringReserveSettledWithoutCash2.

The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's restructuring reserve settled without cash2.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Henry Schein's restructuring reserve settled without cash2?: Henry Schein (HSIC) reported restructuring reserve settled without cash2 of $2M in Q1 2026.
How has Henry Schein's restructuring reserve settled without cash2 changed year-over-year?: Henry Schein's restructuring reserve settled without cash2 increased by 100.0% year-over-year, from $1M to $2M.